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- Medicines cannot be sold without prior registration 
› 4 kinds of registration 
- Centralized European registration: the drug is allowed to be put on the market in all 
the 28 countries of European Union (European Medicines Agency – EMA) 
- Decentralized European registration: the drug is allowed to be put on the market in 
some countries of European Union 
- Mutual recognition registration: a drug which is already put on the market in some 
countries can also be put on the market in some other European countries 
- National registration: valuable in only one European country  
› Registration is materialized by a number, which must be mentioned on the 
packaging of the drug 
- Tamper evident seal on drugs that are subject to counterfeiting 
 
Marketing authorization (A.M.M.) 
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Notification and CE marking 
▶ FOODS SUPPLEMENTS 
- Must be notified to the authorities 
- No « authorization », but possibility of withdrawal if considered 
as« harmful » 
- Receive a « notification number » which 
› must not be mentioned on their packaging but 
› Can be found on a specific website 
▶ MEDICAL DEVICES 
- Approved by an independant « notified body » 
- « CE » marking + identification of the manufacturer  
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Authorizations for manufacture or distribution of 
drugs 
▶ Each manufacturer of drug must hold a specific authorization 
(« manufacturing authorization ») 
- Each operation resulting in a transformation of a drug is considered as 
« manufacture »: including packaging, labeling etc. 
- Inspections by Belgian health authorities on a regular basis, when 
established in Belgium, verifying the respect of Good Manufacturing 
Practices (GMP) 
- Recognition of inspections made in other european countries, because 
based on the same international requirements 
- Pharmaceutical Inspection Convention (PIC): recognition of inspections 
made by authorities in a lot of non-european countries (but not 
Vietnam) 
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The wholesaler and « wholesaler distributor » 
▶ Wholesaler distributes in Belgium (or in Europe) selected 
drugs he doesn’t manufacture himself. 
▶ Wholesaler distributor (« grossiste –répartiteur ») sells 
pharmacists all drugs they need (« middlemen » between  
manufacturers or wholesalers and pharmacists) 
▶ Each wholesaler  and « wholesaler distributor » must have 
a specific authorization (« distribution authorization » or 




The « drug chain » 
▶ Each authorization holder (manufacturer, distributor, wholesaler etc.)  
- can only buy medicines from other authorization holders 
- can only sell medicines to other authorization holders or pharmacies 
▶ Pharmacists (including hospital pharmacists) can only buy medicines from 
authorization holders 
▶ Each party is responsible for verifying suitability and competence of each 
other 
▶ Pharmacists can only sell medicines to patients (not to other pharmacists 
or third parties) 
▶ Consequently, the « drug chain » is locked up from the beginning to the 
end, what prevent falsifications 
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Obligations of the « wholesaler distributor » 
▶ Adequate and sufficient supply of drugs (min. 2/3 of all drugs on 
the market) 
▶ Purchase of medicines only from authorized manufacturers or 
wholesalers 
▶ Sale of medicines only to hospital or primary care pharmacies 
▶ Respect of delivery time (max. 24 hours, usually 3-4 hours) 
▶ Sufficient personal and means of transportation 
▶ Respect of Good Distribution Practices 
▶ Week-end duties for pharmacists on duty 
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Good distribution practices (GDP) 
▶ Source: European guideline of 2013 
▶ Applies to all distributors and wholesalers of 
medicines 
▶ Aim 
- To maintain the quality of each medicine from the 
manufacturer to the pharmacy (including) 
- To prevent falsified medicines to enter the legal supply 
chain 
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Good distribution practices (requirements) 
▶ Management of quality 
- Set up of a quality system in order to meet the aim 
- This quality system has to 
› Ensure the respect of the GDP 
› Identify the respective responsibilities 
› Ensure that products are delivered to the right recipients 
› Document, investigate and correct deviations from 
established procedures 
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Good distribution practices (cont.) 
▶ Personnel 
- Responsible (or qualified) person 
› Industry pharmacists at manufacturers and distributors 
› « common » pharmacist at the wholesaler-distributors 
- Other personnel in adequate number, competent 
and trained (initial and continuing training) 
- Health, hygiene and clothing procedures 
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Good distribution practices (cont.) 
▶ Premises and equipment 
- Medicinal products stored in segregated and clearly marked areas 
- Narcotics stored separate in a key-locked room 
- Clear separation of the receipt, storage and dispatch areas 
- Premises appropriately cleaned, and protected against intrusion of 
insects, rodents etc. 
- No food, drink, smoking material or medicinal products for personal 
- Temperature and environment controls  
- Securing of the computerized systems 
- Qualification and validation of the equipment 
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Good distribution practices (cont.) 
▶ Documentation 
- all written procedures, instructions, contracts, records and 
data, in paper or in electronic form, have to be documented, 
approved, dated and signed by the responsible person 
- Tracability of any transaction in medicinal products received, 
supplied or brokered with 
› quantity received or supplied 
› name and address of the supplier or customer,  
› batch number at least for medicinal product bearing the safety 
features 
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Good distribution practices (cont.) 
▶ Operations 
- Qualification of suppliers and customers (see « drug chain ») 
- Investigation of any irregularity in the sales patterns of narcotics, 
psychotropic substances or other dangerous substances – report 
to competent authorities 
- Storage 
› In appropriate conditions (temperature, humidity, light etc.) 
› “first expiry, first out” 
› Elimination of the nearly expired medicines, with separate holding and 
destruction as soon as possible (documented) 
› Prevent mistakes and mix-ups during picking 
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Good distribution practices (cont.) 
▶ Complaints (of customers)  
- Must be recorded, investigated with appropriate follow-up actions if 
necessary 
▶ Returned medicinal products (from the pharmacies) 
- Can only be put back in saleable stock if 
› in their unopened and undamaged secondary packaging;  in good condition; not 
expired 
› returned within an acceptable time limit, for example 10 days 
› transported, stored and handled in compliance with their specific storage 
requirements (especially products requiring specific temperature storage 
conditions such as low temperature) 
› examined and assessed by a trained and competent person 
› no reason to believe that the product has been falsified 
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Good distribution practices (end) 
▶ Falsification 
- Wholesale distributors must immediately inform the competent authority and the 
marketing authorisation holder of any medicinal products they identify as falsified 
or suspect to be falsified 
▶ Self-inspections are mandatory and have to be documented 
▶ Transportation 
- Must ensure protection of  medicinal products against breakage, adulteration and 
theft 
- Required storage conditions for medicinal products should be maintained during 
transportation within the defined limits – validation and controls are necessary 
- Deliveries should be made to the address stated on the delivery note, and not 
somewhere else (i.e. during the closing hours of the pharmacy) 
- Containers must be validated and correctly labeled 
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Practically for the pharmacist… 
▶ Each pharmacist has 2-3 different wholesalers-distributors 
▶ Each sale of medicine or other product is recorded in the computer, which 
manages the stock 
▶ When the minimal stock fixed by the pharmacist for a product is reached, 
the computer suggests recommending the product, in quantity fixed in 
advance 
▶ The pharmacist orders the drugs and health products he needs from one 
of his wholesalers 
▶ Daily 3-5 orders (except week-end) 
▶ He receives his order within 2-4 hours (legal maximum 24 hours) 
▶ Returns of drugs from pharmacy to wholesaler are (very) difficult 
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▶ Batch number (in coded form) on each drug packaging + expiration date (in clear 
form) 
▶ CNK (« National Code Number ») = barcode (7 digits) 
- Different for each product (drug, health product, cosmetic, medical device) 
- Avoid mistakes while ordering the product (by scanning the barcode)  
▶ CBU (« Unic barcode »): 16 digits (= CNK + 9 digits) 
- Different for each packaging of drug 
- Scanned at the time of dispensing 
- Allows traceability to the patient 
- Prevents treachery (drugs non dispensed although paid to the pharmacist by social security) 
▶ Safety feature: concerns only several medicines exposed to be falsified 
▶ Compounded drugs are also traceable within the pharmacies, to the patient. 
Traceability of drugs 
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▶ Manufacturer, distributor and wholesaler: according to GDP, have to 
- store drugs « in appropriate conditions » 
- « in the fridge » = between 2 and 8°C 
- Fridges must be qualified, validated and continuously controlled  
▶ Transport: see GDP above 
- It must be validated and controlled that, during transportation (cars, pickups), temperature in 
the packaging of the drug doesn’t rise above 8°C 
- Use of cool bags is widespread 
▶ Pharmacist 
- Moves the drugs to the fridge upon receipt 
- Has to  
› Validate his fridge (coldest and warmest places)  
› control its internal temperature at least once daily 
▶ After the pharmacist (patient): ?? 
Cold chain 
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▶ Pharmacy which intend to sale drugs by internet must be notified to the 
health authorites 
▶ Website strongly regulated 
▶ European safety logo on each page of the website 
▶ Only OTC drugs 
▶ If sale outside of Belgium, only OTC drugs registered  
       in the destination country 
▶ For transportation, the pharmacist has to collaborate with reliable courier 




Internet sales of drugs 
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▶ The drug control laboratory (« service de contrôle des médicaments » or SCM) is 
part of the Belgian Association of Pharmacists (APB) 
▶ Controls on a regular time basis all the drugs authorized on the Belgian market 
▶ Financed by the all the primary care  pharmacies: a little part (about 1,5 eurocent) 
of the sale price of each sold packaging of drug is automatically reassigned to the 
SCM 
▶ Alerts each pharmacist in case of detected defect 
▶ Collaborates with Health Authorities and pharmaceutical companies to alert 
pharmacists in case of defects detected by others 
▶ Organizes the recall of the defective medicines from the pharmacies and their 
return to the companies  
▶ Is organizing a system of regular control of the compounding drugs 
 
« Drug control laboratory » of the pharmacists 
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▶ Belgian « Federal Agency for Drugs and Health Products » 
- Controls on a regular basis all the distribution chain 
› Directly for authorization holders established in Belgium 
› Recognition of inspections made in the countries being part of the Pharmaceutical 
Inspection Convention (PIC) 
› Possible joined inspections with local authorities for drugs manufactured outside 
Belgium (PIC members) 
› Control of all primary care pharmacies 
- Schedules an annual check of all specialized drugs containing some active 
ingredients 
- Collects randomly other specialities or compounded drugs 
- Makes analyze these samples by approved laboratories 
▶ Belgian « Federal Agency for the Security of the Food Chain » 
- Id. for food supplements, baby milks… 
Other controls 
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▶ Drugs are withdrawn from market 
- When expired 
› Before selling: destruction by an approved body 
› Returned by patients to the pharmacy: wasting and destruction 
organized by the Walloon (Belgian) authorities 
- When defective of falsified: 
›  R.A.S system in collaboration with European Medicine Agency (EMA) , 
European national authorities and Non-european authorities 
› Pharmacists are warned by the Federal Agency of Drugs and 
Healthproducts through professional associations of pharmacists  
› Recall and destruction  organized by authorization holders through 
professional associations of pharmacists 
Withdrawal of drugs 
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